Evidence map›Paper›PMID 17209779›Full record

ArticleJournal of periodontology2006

Characterization of minocycline transport by human neutrophils.

John D Walters

Abstract readComparative Study
In one paragraph

Article in Journal of periodontology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Pharmacokinetics of doxycycline in adults with cystic fibrosis.Antimicrobial agents and chemotherapy · 2012
    Trial
  2. Review
  3. Article
  4. Intracellular Penetration and Effects of Antibiotics onAntibiotics (Basel, Switzerland) · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection.Journal of the American College of Cardiology · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

John D WaltersSection of Periodontology, College of Dentistry, The Ohio State University Health Sciences Center, Columbus, OH 43210, USA. walters2@osu.edu
The Ohio State University · US

Funding

Uptake of Fluoroquinolones and Tetracyclines by GingivaR01DE012601 · NIDCR · OHIO STATE UNIVERSITY · PI WALTERS, JOHN DOUGLAS · 1998 to 2003
$744k
NIDCR NIH HHS DE12601NIDCR NIH HHS R01 DE012601
6 · The paper itself

Abstract

backgroundTetracyclines are used in periodontal therapy as antimicrobial agents and as inhibitors of matrix metalloproteinases. Neutrophils appear to accumulate minocycline and other tetracyclines through a mechanism that has not been fully characterized.

methodsThe transport of minocycline and other tetracyclines by isolated human neutrophils was characterized by measuring the increase in cell-associated fluorescence.

resultsQuiescent neutrophils took up minocycline through a saturable, concentrative, sodium-dependent mechanism with a Michaelis constant (K(m)) of 153 micro g/ml (501 microM) and a maximal velocity of 240 ng/minute/10(6) cells. The efficiency of minocycline transport was not influenced significantly by a two-unit variation in extracellular pH and was not enhanced upon cell activation with phorbol myristate acetate. Neutrophil incubation in medium containing 10 micro g/ml minocycline, doxycycline, or tetracycline yielded steady-state intracellular/extracellular concentration ratios of approximately 64.0, 7.5, or 1.8, respectively. The dilution of extracellular minocycline or doxycycline triggered efflux from cells loaded with these antibiotics. Minocycline transport was competitively inhibited by the organic cations carnitine, diphenhydramine, and verapamil, but penicillin and other organic anions failed to produce inhibition.

conclusionTransport of tetracyclines by neutrophils could potentially enhance the effectiveness of these agents in periodontal therapy by enhancing or sustaining their therapeutic levels at inflammatory sites and by enhancing the killing of phagocytosed bacterial pathogens.

Indexed as

AdultAnti-Bacterial AgentsBiological TransportCells, CulturedDoxycyclineFemaleHumansHydrogen-Ion ConcentrationIntracellular FluidMaleMiddle AgedMinocyclineNeutrophilsReference ValuesTetracyclineAnti-Bacterial AgentsDoxycyclineMinocyclineTetracycline

Identifiers

PMID17209779
PMCPMC2241670
OpenAlexW1983780879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.